Navigation Links
Gift Aids Professor's Research into Vein Treatment
Date:12/1/2008

ted researcher the tools to do high-level research that could one day advance its company.

"VNUS is pleased to support the work of Dr. Sinjae Hyun and the biomedical engineering program at Mercer University," said Brady Esch, Director of Marketing Development and Product Integration with VNUS. "When I heard of Dr. Hyun's interest in developing a student project concerning treatment of venous disease with our radiofrequency catheters, I immediately saw the merits of combining student learning with an avenue for development of technology. VNUS is a committed leader in the development of medical devices, and we also support the development of future engineers and scientists that may someday add to the ranks of medical device companies like our own."

About VNUS Medical Technologies, Inc.
Founded in 1995 and headquartered in San Jose, Calif., VNUS Medical Technologies (Nasdaq: VNUS - News) is a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that causes the varicose veins afflicting 25 million Americans. The pioneering company in the field, VNUS now offers the ClosureFAST system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. VNUS devices have been used in more than 350,000 procedures worldwide. For more information, visit www.vnus.com.

About Mercer University:
Founded in 1833, Mercer University is a dynamic and comprehensive center of undergraduate, graduate and professional education. The University has more than 7,500 students; 11 schools and colleges - liberal arts, law, pharmacy, medicine, business, engineering, education, theology, music, nursing and continuing and professional studies; major cam
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. Aldrich(R) Releases Materials Science Catalog That Includes Products to Advance Sustainable Energy and Nanotechnology Research
2. Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
3. Update: Georgia and North Carolina Teens Honored for Research in Biochemistry and Genetics in Nations Premier High School Science Competition
4. New Young Investigator Grants for Probiotics Research Announced
5. DuPont Opens Research & Development Center in India
6. Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models
7. VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research
8. Cascades Technologies, Inc. Chosen to Deliver IT Support on a DoD Blast Injury Research Program
9. BOXX Personal Supercomputer for Research Scientists Featured at SC08
10. Putting a new spin on current research
11. Researcher working on destruction of chemical weapons
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gift Aids Professor's Research into Vein Treatment
(Date:9/22/2014)... 22, 2014 Topical BioMedics, Inc., is ... pain end their suffering, restoring hope an quality of ... is only possible because of the innovative cellular biomedicines ... technology a reality. , The company was founded ... Lou Paradise (president, chief of research, and Topricin inventor), ...
(Date:9/22/2014)... Sept. 22, 2014 Research and Markets ... and Chinese Microcrystalline Cellulose Industry Report 2014" report ... Chinese Microcrystalline Cellulose Industry Report 2014 is a professional ... global microcrystalline cellulose industry with a focus on the ... overview of the industry including definitions, classifications, applications and ...
(Date:9/22/2014)... -- Neogen Corporation (Nasdaq: NEOG ) announced today ... 2015 fiscal year, which ended Aug. 31, was $8,883,000 ... $7,839,000 in the first quarter of last year. Adjusted ... earnings per share in the current quarter were $0.24, ... quarter revenues increased 15% to $67,599,000, from the previous ...
(Date:9/22/2014)... LONDON , September 22, 2014 ... ended on a mixed note as the Dow Jones ... NASDAQ Composite closed at 4,579.79, down 0.30%. The S&P ... the trading session, six out of ten sectors finished ... Sector Index ended the day at 751.48, up 0.10%, ...
Breaking Biology Technology:Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 2Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 3Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 4Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 5Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 6Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Neogen reports 13% net income increase 2Neogen reports 13% net income increase 3Neogen reports 13% net income increase 4Neogen reports 13% net income increase 5Neogen reports 13% net income increase 6Neogen reports 13% net income increase 7Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5
... Submission Seeks Approval of Genasense in Relapsed/Refractory Patients, ... (Nasdaq: GNTA ) announced that the Company ... to Dr. Janet Woodcock, Acting,Director of the Center ... and Drug Administration (FDA). The appeal asks that ...
... FRANCISCO, Calif., Oct. 25 Cell,Genesys, Inc. (Nasdaq: ... and chief executive officer, and Sharon E. Tetlow, senior,vice ... host a,conference call relating to the company,s third quarter ... on Thursday, November 1,2007, at 2:00 p.m. PT/ 5:00 ...
... will Include World-Renowned RNase and RNA Researchers, ... mechanics of ribonuclease (RNase) therapeutics will be the ... hosted by Alfacell,Corporation (Nasdaq: ACEL ). ... chief,executive officer, and David Sidransky, M.D., Alfacell,s scientific,advisory ...
Cached Biology Technology:Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 2Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 3Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 4Genta Completes Appeal of FDA Decision for Genasense(R) in CLL 5Cell Genesys to Webcast Third Quarter 2007 Conference Call 2Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29 2Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29 3Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29 4
(Date:9/19/2014)... of dinosaurs a newly discovered hadrosaur with ... named Rhinorex condrupus by paleontologists from ... lived in what is now Utah approximately 75 ... , Rhinorex, which translates roughly into "King Nose," ... other Cretaceous hadrosaurs like Parasaurolophus and Edmontosaurus. Hadrosaurs ...
(Date:9/19/2014)... will study the unique bioelectric signaling system of the ... health. The OU researcher is working to understand ... the signals used to map the world around them. ... of 500-600 discharges a second throughout their lives. ... extreme, but necessary for survival. , "There is evidence ...
(Date:9/19/2014)... sense of fairness did not evolve for the sake ... the benefits of continued cooperation, so say Frans de ... review article about inequity aversion (IA), which is defined ... is published in Science . , Their ... IA-related studies to address their hypothesis that it is ...
Breaking Biology News(10 mins):New hadrosaur noses into spotlight 2Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3
... Indians of Panama, an international team of scientists ... part, responsible, for the heart-healthy benefits of certain ... who are from the University of California, Davis; ... Medical School, hope the findings will lead to ...
... "fingerprinting" techniques, two University of Minnesota researchers have become ... plants with genetic markers. , Hemp, a crop ... the most abundant illegal drug of abuse in the ... They differ in levels of the psychoactive drug tetrahydrocannabinol ...
... used for genetics-versus-environment studies has joined the panoply of ... genomes have been sequenced. , At the Daphnia Genomics ... and Joint Genome Institute scientists announced they've completed a ... as it's better known to high school biology students. ...
Cached Biology News:Heart-healthy compound in chocolate identified 2New DNA 'fingerprinting' technique separates hemp from marijuana 2Genome sequencing is for ecologists, too 2
...
Candida (IgG) -Ab EIA Sample Size: 5 l...
Automated centrifuge for the processing of microplates and tubes; can be integrated into automated process using inexpensive robotics due to its unique sample handling platform....
OptiBuffer is a fully optimised medium, designed for,the electroporation of eukaryotic cells. OptiBuffer,improves both transfection efficiencies and survival,rates over PBS or other standard culture...
Biology Products: